Mitsubishi UFJ Trust & Banking
TEVA icon

Mitsubishi UFJ Trust & Banking’s Teva Pharmaceuticals TEVA Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Buy
484,342
+13,808
+3% +$460K 0.04% 391
2026
Q1 		$14.2M Buy
470,534
+491
+0.1% +$15.8K 0.03% 413
2025
Q4 		$14.7M Buy
470,043
+11,145
+2% +$275K 0.03% 417
2025
Q3 		$9.27M Sell
458,898
-17,932
-4% -$315K 0.02% 570
2025
Q2 		$7.99M Buy
476,830
+13,077
+3% +$211K 0.02% 604
2025
Q1 		$7.13M Sell
463,753
-114,512
-20% -$2.05M 0.02% 616
2024
Q4 		$12.7M Buy
578,265
+75,982
+15% +$1.38M 0.03% 513
2024
Q3 		$9.05M Sell
502,283
-1,460
-0.3% -$25.6K 0.02% 591
2024
Q2 		$8.19M Sell
503,743
-67,188
-12% -$1.03M 0.02% 590
2024
Q1 		$8.05M Sell
570,931
-25,375
-4% -$320K 0.02% 604
2023
Q4 		$6.23M Sell
596,306
-20,657
-3% -$193K 0.01% 651
2023
Q3 		$6.29M Sell
616,963
-15,252
-2% -$142K 0.02% 643
2023
Q2 		$4.76M Sell
632,215
-9,913
-2% -$80.4K 0.01% 694
2023
Q1 		$5.68M Buy
642,128
+15,614
+2% +$154K 0.01% 659
2022
Q4 		$5.71M Buy
626,514
+23,749
+4% +$207K 0.01% 653
2022
Q3 		$4.86M Buy
602,765
+25,428
+4% +$225K 0.01% 666
2022
Q2 		$4.34M Buy
577,337
+95,325
+20% +$830K 0.01% 691
2022
Q1 		$4.53M Sell
482,012
-79,507
-14% -$664K 0.01% 710
2021
Q4 		$4.5M Sell
561,519
-276
-0% -$2.49K 0.01% 741
2021
Q3 		$5.47M Sell
561,795
-17,716
-3% -$166K 0.01% 726
2021
Q2 		$5.74M Sell
579,511
-55,962
-9% -$592K 0.01% 731
2021
Q1 		$7.32M Sell
635,473
-133,654
-17% -$1.53M 0.02% 671
2020
Q4 		$7.42M Sell
769,127
-72,155
-9% -$691K 0.02% 682
2020
Q3 		$7.58M Sell
841,282
-21,097
-2% -$223K 0.02% 633
2020
Q2 		$10.6M Buy
862,379
+63,881
+8% +$722K 0.03% 525
2020
Q1 		$7.17M Buy
798,498
+5,276
+0.7% +$54.1K 0.02% 577
2019
Q4 		$7.77M Sell
793,222
-22,088
-3% -$197K 0.02% 656
2019
Q3 		$5.64M Sell
815,310
-24,803
-3% -$190K 0.01% 701
2019
Q2 		$7.63M Buy
840,113
+107,615
+15% +$1.3M 0.03% 582
2019
Q1 		$11.4M Sell
732,498
-1,886
-0.3% -$33.3K 0.04% 450
2018
Q4 		$11.3M Sell
734,384
-743
-0.1% -$15.2K 0.05% 414
2018
Q3 		$15.8M Sell
735,127
-1,208,394
-62% -$28.1M 0.06% 374
2018
Q2 		$47.3M Buy
1,943,521
+128,469
+7% +$2.62M 0.08% 284
2018
Q1 		$31M Buy
1,815,052
+1,456
+0.1% +$28.4K 0.05% 381
2017
Q4 		$34.4M Buy
1,813,596
+5,429
+0.3% +$81.7K 0.06% 352
2017
Q3 		$31.8M Sell
1,808,167
-9,125
-0.5% -$205K 0.06% 359
2017
Q2 		$60.4M Sell
1,817,292
-27,364
-1% -$847K 0.12% 203
2017
Q1 		$59.2M Sell
1,844,656
-578
-0% -$19.7K 0.12% 204
2016
Q4 		$66.9M Buy
1,845,234
+1,626,352
+743% +$64.9M 0.14% 168
2016
Q3 		$10.1M Buy
218,882
+33,266
+18% +$1.74M 0.02% 636
2016
Q2 		$9.32M Buy
185,616
+4,200
+2% +$224K 0.02% 636
2016
Q1 		$9.71M Sell
181,416
-2,000
-1% -$117K 0.02% 628
2015
Q4 		$12M Buy
183,416
+6,200
+3% +$383K 0.03% 584
2015
Q3 		$10M Buy
177,216
+65,766
+59% +$4.26M 0.02% 609
2015
Q2 		$6.59M Sell
111,450
-18,600
-14% -$1.15M 0.02% 673
2015
Q1 		$8.1M Sell
130,050
-47,500
-27% -$2.76M 0.02% 642
2014
Q4 		$10.2M Sell
177,550
-26,000
-13% -$1.45M 0.02% 617
2014
Q3 		$10.9M Buy
203,550
+5,950
+3% +$315K 0.03% 589
2014
Q2 		$10.4M Buy
197,600
+12,100
+7% +$618K 0.02% 607
2014
Q1 		$9.8M Sell
185,500
-39,000
-17% -$1.8M 0.02% 606
2013
Q4 		$9M Buy
224,500
+210,000
+1,448% +$8.27M 0.02% 630
2013
Q3 		$548K Sell
14,500
-182,000
-93% -$7.1M ﹤0.01% 717
2013
Q2 		$7.7M Buy
+196,500
New +$7.65M 0.02% 621

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's TEVA Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking increased its Teva Pharmaceuticals (TEVA) stake by 2.9% in Q2 2026, buying an estimated $460K and bringing the position to 484,342 shares worth $16.4M. The position accounts for 0.04% of the portfolio, ranked #391.

Mitsubishi UFJ Trust & Banking first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $66.9M in Q4 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 484,342 shares of Teva Pharmaceuticals worth $16.4M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking bought 13,808 Teva Pharmaceuticals shares in Q2 2026, an estimated $460K.
  • Teva Pharmaceuticals made up 0.04% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #391 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Mitsubishi UFJ Trust & Banking's Teva Pharmaceuticals position peaked at $66.9M in Q4 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.